Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (1) , 41-62
- https://doi.org/10.2165/00003088-200140010-00004
Abstract
This review discusses several issues in the clinical pharmacology of the antitumour agent ifosfamide and its metabolites. Ifosfamide is effective in a large number of malignant diseases. Its use,...Keywords
This publication has 174 references indexed in Scilit:
- Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1997
- Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatricsEuropean Journal Of Cancer, 1996
- Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patientsEuropean Journal Of Cancer, 1995
- L-carnitine: a way to decrease cellular toxicity of ifosfamide?European Journal of Pediatrics, 1995
- Comparison of continuous infusion and bolus administration of ifosfamide in childrenEuropean Journal Of Cancer, 1995
- Hallucinations and ifosfamide-induced neurotoxicityCancer, 1994
- Ifosfamide/MesnaDrugs, 1991
- Ifosfamide encephalopathy: a reappraisalEuropean Journal of Cancer and Clinical Oncology, 1989
- Prediction of Ifosfamide/Mesna associated encephalopathyEuropean Journal of Cancer and Clinical Oncology, 1986
- Interindividual Variations in Drug DispositionClinical Pharmacokinetics, 1983